![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Fermion Oy](https://www.pharmacompass.com/image/flap/fermion-w25-desktop-headergif1gif-40022.gif)
![Fermion Oy](https://www.pharmacompass.com/image/flap/fermion-w25-mobgif-50310.gif)
Active Filter(s):
Details:
Through the acquisition, Dr. Reddy expand its women’s health and dietary supplement branded portfolio, including MenoFit and MenoGlow probiotics to address the symptoms of menopause.
Lead Product(s): Bifidobacterium Animalis,Lactobacillus Gasseri,Lactobacillus Plantarum
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: MenoFit
Highest Development Status: Approved Product Type: Large molecule
Partner/Sponsor/Collaborator: Dr. Reddy\'s Laboratories
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition January 03, 2024